Publications by authors named "Ziling Zhan"

Claim this Profile
T
TRAF3 loss protects glioblastoma cells from lipid peroxidation and immune elimination via dysregulated lipid metabolism.
Yu Zeng, Liqian Zhao, Kunlin Zeng, Ziling Zhan, Zhengming Zhan, Hongchao Zhan

J Clin Invest· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RBPWorld for exploring functions and disease associations of RNA-binding proteins across species.
Jian-You Liao, Bing Yang, Chuan-Ping Shi, Wei-Xi Deng, Jin-Si Deng, Zi-Ling Zhan, Yu-Chan Zhang

Nucleic Acids Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCAF13-mediated K63-linked ubiquitination of RNA polymerase I promotes uncontrolled proliferation in Breast Cancer.
Zhi-Zhi Yang, Bing Yang, Haiyan Yan, Xingyu Ma, Bin Tian, Ziling Zhan, Jing Yuan Zhang, Yin Zhang, Yu-Chan Zhang

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity.
Li Wang, Cuiying Li, Hongchao Zhan, Shangbiao Li, Kunlin Zeng, Ziling Zhan

Cell Rep Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.
Shangbiao Li, Yanwen Chen, Yuxin Xie, Hongchao Zhan, Yu Zeng, Ziling Zhan

Adv Sci (Weinh)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEC61G assists -amplified glioblastoma to evade immune elimination.
Kunlin Zeng, Yu Zeng, Hongchao Zhan, Ziling Zhan, Li Wang

Proc Natl Acad Sci U S A· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis.
Zelong Han, Ming Liu, Yuxin Xie, Kunlin Zeng, Ziling Zhan, Hongchao Zhan, Keqin Zhang

Cell Death Discov· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Yu Zeng, Yonghua Cai, Peng Chai, Yangqi Mao, Yanwen Chen, Ziling Zhan, Hongchao Zhan

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis